Neural stem cells (NSCs) expressing GFP were embedded into fibrin matrices containing growth factor cocktails and grafted to sites of severe spinal cord injury. Grafted cells differentiated into multiple cellular phenotypes, including neurons, which extended large numbers of axons over remarkable distances. Extending axons formed abundant synapses with host cells. Axonal growth was partially dependent on mammalian target of rapamycin (mTOR), but not Nogo signaling. Grafted neurons supported formation of electrophysiological relays across sites of complete spinal transection, resulting in functional recovery. Two human stem cell lines (566RSC and HUES7) embedded in growth-factor-containing fibrin exhibited similar growth, and 566RSC cells supported functional recovery. Thus, properties intrinsic to early-stage neurons can overcome the inhibitory milieu of the injured adult spinal cord to mount remarkable axonal growth, resulting in formation of new relay circuits that significantly improve function. These therapeutic properties extend across stem cell sources and species.
INTRODUCTION
Research over the last several decades has revealed numerous molecular mechanisms in the environment of the adult central nervous system (CNS) that contribute to the failure of axonal regeneration after injury, including myelin-associated proteins that inhibit axonal growth (He and Koprivica, 2004; Buchli and Schwab, 2005) , the deposition of inhibitory extracellular matrix molecules around injury sites (Fawcett, 2006; Fitch and Silver, 2008) , and the lack of positive environmental stimuli such as growth factors (Tuszynski and Lu, 2008) . The observation that at least some classes of adult CNS axons can grow over long distances in peripheral nerve bridges supports the view that the adult CNS environment is inhibitory (David and Aguayo, 1981; Houle et al., 2006) . However, some studies indicate that neuron-intrinsic mechanisms also contribute to axonal growth failure in the adult CNS (Filbin, 2006; Kadoya et al., 2009) . Indeed, the extent to which neuron-intrinsic mechanisms alone can overcome the inhibitory growth environment of the adult CNS is actively debated. To address this question, we grafted either freshly dissociated neural stem cells/progenitors from green fluorescent protein (GFP)-expressing rat embryos (Bryda et al., 2006; Baska et al., 2008; Mayer-Proschel et al., 1997) or cultured human stem cells derived from two different sources (HUES7 cells and 566RSC cells from NeuralStem, Inc.) to the adult lesioned spinal cord. Expression of the GFP reporter gene in all cells provides an unprecedented opportunity to track the fate, integration, process extension, and differentiation of grafted cell types within the inhibitory milieu of the adult injured spinal cord.
We now report a remarkable capability of early-stage neurons from different sources and species to survive, integrate, and extend axons over very long distances and to form functional relays in the lesioned adult CNS. These findings indicate that, despite the inhibitory milieu of the adult CNS, neuron-intrinsic mechanisms are sufficient to support remarkably extensive axonal growth and synapse formation after spinal cord injury, resulting in formation of new neuronal relays that restore electrophysiological activity and behavior. Moreover, stem cells across species exhibit these properties, supporting the intrinsic capabilities of these cells and suggesting translational relevance.
RESULTS
Fischer 344 adult rats underwent T3 complete spinal cord transection. Two weeks later, a clinically relevant time point, we dissected embryonic day 14 (E14) spinal cords from Fischer 344 rats ubiquitously expressing the GFP reporter gene. Grafts were trypsinized and implanted as suspensions (Giovanini et al., 1997) but survived only at the host/lesion margins and failed to fill the complete transection site. To enhance graft survival and filling of the lesion, in new experiments, the E14 neural stem cells were embedded into fibrin matrices containing a cocktail of growth factors (n = 26 rats; see Experimental Procedures). Animals then underwent functional and electrophysiological studies and were perfused 9 weeks after the initial injury.
Anatomical analysis revealed that grafted cells completely and consistently filled the lesion cavity when assessed 7 weeks postgrafting (Figures 1A and 1B) . Grafted cells were not observed to migrate into the host beyond the immediate region of the graft/ lesion site. Grafted cells primarily differentiated into neurons (27.5 ± 2.7% of all GFP-labeled cells), oligodendroglia (26.6 ± 3.9%), and astrocytes (15.9 ± 1.6%) . Numerous large GFP-labeled cells colocalized with the mature neuronal markers NeuN ( Figures  1C-1H ), bIII tubulin (Tuj1), and MAP2 ( Figures S2A and S2B ). In addition to expressing mature neuronal markers, many grafted cells also expressed choline acetyltransferase (ChAT), characteristic of spinal motor neurons, and the inhibitory neuronal marker glutamic acid decarboxylase 67 (GAD67) (Figures S2C and S2D) .
Graft-derived spinal cord neurons extended large numbers of axons into the host spinal cord in both rostral and caudal directions over remarkably long distances (Figure 2 ). Emerging GFPlabeled processes from grafts were axons, as demonstrated by colabeling for the axonal marker neurofilament (Figure 2A ). In the cephalad (rostral) direction, graft-derived axons extended to C6 in all subjects examined (n = 6) and extended a distance of 25 mm from the T3 transection cavity into the C4 cervical segment in five of six subjects (Figures 2E and 2F) . Graft-derived axons also extended caudally to the lower thoracic spinal cord (T10) in all subjects (n = 6), continuing to the upper lumbar spinal cord, which is a distance of more than nine spinal segments (25 mm), in four of six subjects (Figures 2A-2D , 2G, and 2H). All animals with caudal extension of axons to L1 also exhibited rostral extension of axons to C4, indicating that long-distance, bidirectional axonal growth occurred commonly. To estimate the magnitude of axon outgrowth that can be achieved by implantation of neural primordia into sites of spinal cord injury, we stereologically (Rosenzweig et al., 2010) quantified 29,000 GFP-labeled axons emerging from the graft in the caudal direction (0.5 mm caudal to the T3 transection site). This number likely represents an underestimation, as dense bundles of axons that could not be individually resolved were counted as single axons. The density of axons emerging from grafts was highly consistent among all six subjects examined ( Figure S3 ). In 12 additional subjects, progressive axon emergence from the lesion/graft site was serially examined at time points of 1, 2, 3, and 7 days postgrafting (n = 3 rats per time point). Axons emerged from the graft/lesion site by day 2 after grafting and extended at a rapid rate of 1-2 mm/day ( Figure S4 ). The visualization of axon growth over time documents the extension of new axons and excludes the possible artifact that grafted cells fused with host neurons. Thus, axons extended in remarkably large numbers and over long distances, including extension through adult white matter. Indeed, time course studies indicated that initial axon outgrowth preferentially occurred through white matter ( Figure S4 ).
Graft-derived axons in host white matter were frequently myelinated by host oligodendrocytes (i.e., cells myelinating graft-derived axons were not labeled for GFP; Figures 3A  and 3B ). In addition, grafted cells that differentiated into neurons extended axons from the spinal cord lesion site into adjacent host ventral roots in every subject examined, with 6.8 ± 1.2 graft-derived axons quantified per 40-mm-thick section of ventral root ( Figure S2E ). 56.7 ± 5.3% of these ventral root axons expressed the appropriate phenotypic motor neuronal marker ChAT ( Figure S2F ), likely derived from ChAT-expressing motor neurons inside grafts ( Figure S2C ). GFP-labeled axons were rarely detected in dorsal roots.
GFP-labeled, graft-derived axons in the host spinal cord formed dense bouton-like terminals around host dendrites and cell bodies, identified by labeling for the neuronal somal and dendritic markers MAP-2, the neuronal somal marker Tuj1 (bIII tubulin), and the motor neuron marker ChAT (Figures 3C-3E ). Double immunofluorescent labeling for GFP and synaptophysin suggested synapse formation between grafted and host neurons in both rostral and caudal directions ( Figure 3E ) at all distances from the lesion site, including sites sampled 25 mm from the injury. Immunoelectron microscopy confirmed synapse formation between GFP-labeled graft-derived axons and host neurons and dendrites ( Figure 3F ). Further, GFP-labeled terminal boutons expressed either the excitatory transmitter marker vesicular glutamate transporter 1/2 (vGlut1/2) or the inhibitory marker glutamic acid decarboxylase 65 (GAD65) (Figures 3G and 3H ). Many instances of colocalization of these terminal region markers with ChAT were also found ( Figures 3G and 3H ). Collectively, these findings demonstrate exuberant projections of neural stem-cell-derived axons from sites of spinal cord injury into the adult spinal cord together with synapse formation.
Neurons of the developing spinal cord express receptors to myelin-associated inhibitors such as Nogo (Josephson et al., 2002) , a finding that we confirmed in the present study in grafted tissue ( Figure S5A ). Thus, insensitivity to myelin-based inhibitors is an unlikely mechanism to account for the robust growth of axons observed in this study. Recently, the tumor suppressor gene ''phosphatase and tensin homolog'' (PTEN) has been identified as a major neuron-intrinsic regulator of axonal regeneration in the adult CNS (Park et al., 2008) . PTEN inhibits the activity of ''mammalian target of rapamycin'' (mTOR), and neuronal knockout of PTEN has been reported to enhance central axonal regeneration (Park et al., 2008; Liu et al., 2010; Sun et al., 2011) . To determine whether mTOR signaling is a mechanism contributing to the extensive growth of neural stem-cell-derived axons through the lesioned adult CNS, we injected rapamycin, an mTOR inhibitor, into rats beginning 2 days after placement of grafts into the lesion site (6 mg/kg intraperitoneally, n = 6 rats; seven controls underwent vehicle injections). When examined 2 weeks later, rats subjected to mTOR blockade exhibited a significant, 50% reduction in graft-derived axonal outgrowth from the lesion compared to vehicle-injected controls (p < 0.05; Figures 4A and S5B-S5E). Labeling for phospho-S6 (p-S6), an indicator of mTOR activity (Park et al., 2008) , demonstrated abundant expression in graft-derived neurons and substantial reduction following rapamycin treatment (Figures S5H-S5J). Rapamycin injection did not alter neural stem cell graft survival or differentiation (Figures S5F, S5G, and S5K ). These findings demonstrate mTOR signaling as a mechanism contributing to the ability of early-stage neurons to extend axons in the adult lesioned CNS.
Importantly, host axons also penetrated neural stem cell grafts in spinal cord lesion sites, including biotin dextran amine (BDA)-labeled reticulospinal axons and 5-hydroxytryptamine (HT)-labeled serotonergic (raphespinal) axons ( Figures 4B-4G ). Host inputs into grafts were both locally and supraspinally derived. Although host supraspinal axons regenerated into grafts, in no case did they regenerate beyond the graft into host spinal cord parenchyma caudal to the lesion site. Like graft-derived axons, host axons penetrating grafts colocalized with the synaptic marker synaptophysin ( Figure 4F ), establishing a mechanism for host-to-graft connectivity.
Functional and behavioral outcomes were measured in subjects that underwent T3 complete spinal cord transections and, 2 weeks later, neural stem cell implants in the lesion site ( Figure 5A ). Hindlimb locomotion was severely impaired in both lesion control and grafted subjects for the first 4 weeks postinjury; in week 5 (3 weeks postgrafting), recipients of neural stem cell grafts exhibited significant improvement on the Basso, Beattie, and Bresnahan (BBB) scale (Basso et al., 1996) , reaching a functional plateau by 8 weeks postlesion (p < 0.01). The mean BBB score reached a level of seven, indicating movement about each joint of the hindlimb, in contrast to minimal movement, if any, in lesioned controls. To determine whether functional improvement depended on regeneration of host axons into the graft/lesion site, half of the subjects underwent retransection of the spinal cord just rostral to the T3 graft, resulting in a complete abolition of behavioral recovery when measured 1 week later ( Figures 5A and S6) .
To confirm the dependence of functional recovery on host axonal regeneration into the lesion site, electrophysiological measurements were made in six subjects. A stimulating electrode was placed in the dorsal C7 spinal cord (three spinal segments above the lesion), and recordings were made at T6 (three spinal segments below the lesion). In intact animals, stimulation at C7 evoked a short latency (3.42 ± 0.32 ms) response ( Figure 5B, i) that was entirely abolished by T3 complete transection ( Figure 5B , ii). In two-thirds of animals with neural stem cell grafts in the lesion site, evoked responses were restored ( Figure 5B, iii) . Response latencies in the grafted group were prolonged (5.47 ± 0.24 ms, compared to 3.42 ± 0.32 ms in intact subjects, p < 0.05), suggesting formation of polysynaptic relays through the graft. Response amplitudes in the grafted group (0.09 ± 0.03mV) were smaller than intact subjects (0.27 ± 0.12mV) (p < 0.05; Figure 5B , iii). Notably, retransection of the spinal cord just rostral to the T3 graft completely abolished detectable activity upon C7 stimulation, even when using high intensity stimuli ( Figure 5B, iv) . To determine whether responses detected at T6 depended on the presence of synapses in the graft, the N-methyl-D-aspartic acid (NMDA) receptor blocker kynurenic acid (50 mM) was applied to the graft at T3, 7 weeks postlesion. Kynurenic acid resulted in a significant, 50% reduction in the amplitude of the response recorded at T6 but did not affect latency of the response, indicating that excitatory synaptic transmission across the graft was required for detection of caudal transmission ( Figure 5C ).
Thus, early-stage neurons grafted in a fibrin matrix containing a growth factor cocktail extend large numbers of axons over long distances in the lesioned spinal cord and form neuronal relays that significantly improve electrophysiological and functional outcomes. The magnitude of functional effect substantially exceeds those previously reported in studies of fetal or stem cell grafts to the injured spinal cord, possibly due to enhanced graft survival generated by coimplantation with fibrin matrices containing growth factors. These results suggest strong translational possibilities. Accordingly, we repeated these studies using cultured human neural stem cells.
Six adult female athymic nude rats (T cell deficient) underwent T3 complete transections. One week later, a suspension of neural stem cells derived from human fetal spinal cord (566RSC-UBQT-GFP, see Experimental Procedures; gift of NeuralStem, Inc.) was embedded into fibrin matrices containing a growth factor cocktail, as above. These cells are currently being used in a human clinical trial in amytrophic lateral sclerosis (Boulis et al., 2011) . Function was assessed during the next 7 weeks in grafted animals and was compared to six lesioned controls, and then rats were sacrificed for anatomical studies. Grafts completely and consistently filled lesion cavities ( Figure 6A) , and a majority of grafted cells (57 ± 1.7%) expressed the mature neuronal marker NeuN ( Figure 6B ). As in rat donor studies, remarkable numbers of axons emerged from the grafts and extended for very long distances, over a total of 17 spinal segments ( Figures  6C-6E and 7) . In the rostral direction, axons extended 25 mm above the lesion site to the C4 level ( Figures 7A-7C) , and in the caudal direction, axons reached the upper lumbar spinal cord ( Figures 7D-7F) . GFP-labeled, graft-derived axons formed bouton-like terminals in the host gray matter and expressed human-specific synaptophysin ( Figure 6F ), suggesting synaptic connectivity between grafted human and host rat neurons. Tumor formation by implanted human neurons was not observed within the lesion site or remotely in the host spinal cord. As observed in rat donor studies, grafts of human neural stem cells induced significant locomotor recovery after T3 complete transection ( Figure 6G) , with movement about all joints of the lower extremities. Once again, retransecting the spinal cord immediately rostral to the lesion site abolished hindlimb movement, indicating that functional recovery was dependent on inputs into the graft from the host. (A) Hindlimb locomotion: BBB scores after T3 complete transection show significant improvement in subjects that received neural stem cell grafts (NSC, n = 6) compared to lesioned controls (n = 6). Retransection (arrow, Re-T) at rostral interface of graft with host abolishes functional improvements when assessed 1 week later (**p < 0.01 and ***p < 0.001). Data are represented as mean ±SEM. (B) Electrophysiological transmission across the T3 complete lesion site: (i) in intact animals, stimulation at C7 evoked a short latency ($3.0 ms), large amplitude response at T6; (ii) transection of the cord at T3 completely abolished this response; (iii) in four of six lesion/grafted animals, recovery of an evoked response of prolonged latency ($5.5 ms) was observed; (iv) and retransection of the spinal cord at T3, just rostral to the graft (green arrow), abolished the recovered evoked response. (C) Kynurenic acid (50 mM), a blocker of excitatory synapses, was applied to the graft to determine whether excitatory transmission across synapses in the graft was required to detect responses at T6. Indeed, kynurenic acid application substantially reduced the amplitude, but not the latency, of the evoked response. See also Figure S6 .
To determine whether the ability to extend axons in vivo is a property expressed by stem cells derived from different human sources, we also tested the Harvard University Embryonic Stem cell 7 (HUES7) line (Cowan et al., 2004) . HUES7 cells were neurally induced (Yuan et al., 2011) and embedded in the same growth factor cocktail-containing matrix and then grafted to sites of spinal cord injury ( Figure S7 ); because this component of the study was purely anatomical, we used a C5 lateral spinal cord lesion (hemisection) in which animal care is less difficult. Once again, remarkable numbers of axons extended from the lesion over very long distances, reaching the brainstem in the rostral direction and the lumbar spinal cord caudally ( Figures  S7A-S7G) . In gray matter, these human terminals abundantly expressed the presynaptic marker synaptophysin ( Figure S7H ).
DISCUSSION
Findings of the present study indicate that neural stem cells can specify sufficient information to permit extensive, long-distance CNS axonal regeneration; additional experimental manipulation of the inhibitory environment of the adult CNS is not required to achieve this long-distance regeneration. Moreover, the axon growth arising from neural stem cells can support functional improvement in the most severe model of spinal cord injury, complete spinal transection, when cografted in a supportive fibrin matrix containing a growth factor cocktail. Axons extend (C-E) GFP-expressing human neurons robustly extend axons into the host spinal cord caudal and rostral to the complete T3 transection site (caudal shown). Axons extend through both WM and GM. (F) GFP-labeled human axon terminals express human-specific synaptophysin (hSyn) in host GM. Site shown is 7 mm caudal to lesion. Scale bar, 500 mm (A); 10 mm (B); 600 mm (C); 60 mm (D and E); and 3 mm (F). (G) There is significant functional improvement after human NSC grafts to sites of T3 complete transection (**p < 0.01). Retransection (arrow, Re-T) at rostral interface of graft completely abolishes functional recovery assessed 1 week later, indicating that host inputs are required to improve function. Data are represented as mean ±SEM.
in large numbers and over remarkably long distances to form connections with host axons. Indeed, axons grew through white matter, gray matter, and into ventral roots, and they grew in high density and elongated at a rapid rate of 1-2 mm per day, even through inhibitory white matter. Moreover, host supraspinal axons regenerated into the neural stem cell grafts. This reciprocal growth resulted in a five-point improvement on the BBB scale that reflects recovery of the ability to move all joints of the hindlimbs. The mechanism of recovery, in contrast to previous studies with neural stem cells, is functional relay formation, which is indicated by the abolition of recovery by spinal retransection immediately rostral to the lesion. These findings may accordingly represent the most comprehensive demonstration to date of the ability of new neural relays to support functional recovery, even after the most severe spinal cord injury (Steward et al., 2003) .
Wictorin and colleagues reported in 1990 that early-stage human fetal tissue grafted into partial striatal lesion sites could extend axons for long distances in the mature CNS (Wictorin et al., 1990) . In 1997, Silver and colleagues also supported the concept that neurons could extend axons through adult CNS tissue over long distances by grafting adult dorsal root ganglion neurons to white matter (Davies et al., 1997) . However, these neurons did not extend axons across lesion sites, and functional effects were not studied (Davies et al., 1999) . More recently, Gaillard and colleagues reported long-distance extension of GFP-labeled axons from embryonic grafts placed into cortical lesion sites; this study was anatomical and lacked functional or circuit analysis (Gaillard et al., 2007 ). Fischer's group grafted mixed neuronal and glial-restricted precursors to sites of partial spinal cord injury but reported only modest axonal outgrowth (Lepore and Fischer, 2005) , and subsequent coadministration of growth factors enabled further axonal growth over only short distances of a few millimeters (Bonner et al., 2011) . Previous studies of embryonic stem cell implants to sites of spinal cord injury used moderate and incomplete lesions and reported only modest functional improvements (Cummings et al., 2005) (1-2 points on the BBB scale), with relatively modest graft survival in the lesion site. The classic embryonic spinal cord grafting literature (Jakeman and Reier, 1991; Theele et al., 1996; Bregman et al., 1997; Giovanini et al., 1997; Bamber et al., 1999) used cells of a similar developmental stage to the rodent donor cells in the present study but did not identify the extent to which early-stage neurons were capable of extending very large numbers of axons over extraordinarily long distances in the lesioned adult nervous system; the improved survival, growth, and outcomes in the present study are likely a result of the use of fibrin matrix and a growth factor cocktail, together with clear identification of cell fate and projection using the GFP reporter. Indeed, distances traversed by graft-derived axons in this study exceeded the length of the entire embryonic rat nervous system (Miller et al., 1998) . Findings were not attributable to graft cell fusion with the host, as axons progressively elongated outward from the lesion over several days, which is an observation inconsistent with cell fusion.
Grafts of human neural stem cells exhibited growth that was equally extensive. Two different human cell sources, including 566RSC cells derived from human embryonic spinal cord (Johe et al., 1996) and HUES7 cells derived from human embryonic stem (ES) cells (Cowan et al., 2004; Yuan et al., 2011) , exhibited identical patterns of growth in the injured adult spinal cord after neural induction. Thus, this growth potential is not cell specific or species specific, suggesting translational potential. Indeed, functional testing of 566RSC cells also revealed an ability to support extensive functional improvement in a severe spinal cord injury (SCI) lesion.
Conclusion
We report an extensive number, distance, and functional impact of axonal outgrowth from neural stem cell grafts, embedded in fibrin matrices containing growth factors, to sites of severe spinal cord injury. These findings indicate that properties intrinsic to the early-stage neuron are sufficient to overcome barriers to growth in the adult CNS. There are important potential clinical implications; treatments were delayed for a clinically practical time frame of at least 1 week postinjury, resulted in significant functional improvement, and were achieved by using a human neural stem source already employed in clinical trials for amyotrophic lateral sclerosis (ALS) (Boulis et al., 2011) .
EXPERIMENTAL PROCEDURES Animals
Adult female Fischer 344 rats (160-200 g, n = 55) and athymic nude rats (T cell deficient) (180-200 g, n = 12) were subjects of this study. NIH guidelines for laboratory animal care and safety were strictly followed. Animals had free access to food and water throughout the study. All surgery was done under deep anesthesia by using a combination (2 ml/kg) of ketamine (25 mg/ml), xylazine (1.3 g/ml), and acepromazine (0.25 mg/ml).
Transplantation Surgeries
Adult female Fischer 344 rats and athymic nude rats underwent T3 complete transection. A 2-mm-long block of spinal cord was cut and removed by using a combination of iridectomy scissors and microaspiration, with visual verification to ensure complete transection ventrally and laterally. For rat-donor studies, grafting was performed 2 weeks after T3 transection. Embryonic day 14 (E14) spinal cords from transgenic Fischer 344-Tg (EGFP) rats, ubiquitously expressing GFP under the ubiquitin C promoter, provided donor tissue for grafting (Rat Resource and Research Center, University of Missouri, Columbia, MO). E14 spinal cord was dissected and dissociated according to the method of Harris et al. (2007) . Dissociated E14 cells were resuspended at a concentration of 200,000 cells/ml in a fibrin matrix (25 mg/ml fibrinogen and 25 U/ml thrombin, Sigma F6755 and T5772) containing growth factors to support graft survival (Willerth et al., 2007; Grumbles et al., 2009; Kadoya et al., 2009 ): BDNF (50 mg/ml, Peprotech, 452-02), neurotrophin-3 (NT-3; 50 mg/ml, Peprotech, 450-03), platelet-derived growth factor (PDGF-AA; 10 mg/ml, Sigma, P3076), insulin-like growth factor 1 (IGF-1; 10 mg/ml, Sigma, I8779), epidermal growth factor (EGF; 10 mg/ml, Sigma, E1257), basic fibroblast growth factor (bFGF; 10 mg/ml, Sigma, F0291), acidic fibroblast growth factor (aFGF; 10 mg/ml, Sigma, F5542), glial-cell-line-derived neurotrophic factor (GDNF; 10 mg/ml, Sigma, G1401), hepatocyte growth factor (HGF; 10 mg/ml, Sigma, H9661), and calpain inhibitor (MDL28170, 50 mM, Sigma, M6690). The graft mixture was microinjected into the lesion cavity as a 10 ml cell suspension, and subjects survived another 7 weeks (n = 26). Animals underwent functional testing, electrophysiological assessment, and anatomical analysis and were compared to six lesion-only controls. To identify molecular mechanisms underlying axonal outgrowth from donor cells, 13 additional subjects underwent lesions and rat neural stem cell grafts and then received either rapamycin (LC Laboratories, 6 mg/kg of 20 mg/ml solution; n = 6 animals) or vehicle (n = 7) intraperitoneally every other day starting 2 days postgrafting, as previously described (Park et al., 2008) . Animals survived an additional 2 weeks. An additional 12 subjects underwent lesion and grafts and were perfused 1, 2, 3, or 7 days after transplantation (n = 3 per time point) to examine the time course of axonal outgrowth from the lesion site. Two weeks before perfusion, reticulospinal tract axons were anterogradely labeled by injection of 0.5 ml of 10% biotinylated dextran amine (BDA; MW 10,000, Molecular Probes) into each of four sites spanning both the right and left gigantocellular reticular nucleus (bregma, 11-12.5 mm; lateral, 8 mm; depth, 8.2-7 .3 mm) (Jin et al., 2002) .
For human neural stem cell donor studies, cultured human fetal spinal cord neural stem cells (NSCs) (NSI-566RSC) were provided by NeuralStem, Inc. Methods for procuring cells have been published previously (Johe et al., 1996; Boulis et al., 2011) . Briefly, the cervical and upper thoracic region of an 8 week human fetal spinal cord was dissociated and suspended by trituration in serum-free, modified N2 medium containing 100 mg/l human plasma apo-transferrin, 25 mg/l recombinant human insulin, 1.56 g/l glucose, 20 nM progesterone, 100 mM putrescine, and 30 nM sodium selenite in DMEM/F12. 10 ng/ml FGF2 was added as a mitogen, and cells were serially expanded as monolayer cultures in T175 flasks or 150 mm plates coated with 100 mg/ml poly-D-lysine (Johe et al., 1996) . FGF2 was added every 2 days, and cells were first passaged on day 16. Cells were harvested at each subsequent passage upon reaching 75% confluence and were stored in liquid nitrogen. They were not retained after passage 20. For shipping, cells were thawed 1 day prior to grafting, washed, and shipped overnight to UC San Diego at 2 C -8 C. Viability exceeded 80% the next day. Cells expressed GFP under the ubiquitin C promoter, enabling in vivo tracking of cell survival, differentiation, and process outgrowth. Cells were implanted into spinal cord lesion sites 1 week after T3 complete transection (n = 6 animals) and were compared to lesioned, ungrafted controls (n = 6). Animals survived for 7 weeks and underwent functional testing, as described above. We also grafted a second human stem cell source. Proliferating HUES7 colonies were cultured on mouse fibroblasts and induced to form embryoid bodies. During the nestin-positive stage, the rosettes were removed, singlecell suspensions were prepared, and the CD184 + /CD271
+ population of hES-NSCs were fluorescence-activated cell (FAC)-sorted and expanded in the presence of FGF-2 (Yuan et al., 2011) . Cells were embedded in fibrin matrices containing growth factors as described above and were grafted into sites of C5 hemisection in adult female athymic (nude) rats (n = 6). Comparison was made to lesioned, ungrafted controls (n = 6). Animals survived for 3 months and were sacrificed for anatomical studies, as described above. This was a purely anatomical study; functional outcomes were not examined.
Histology and Immunohistochemistry
Animals were perfused with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2). Spinal cords were dissected, postfixed overnight at 4 C, and then transferred to 30% sucrose for 72 hr. 1.5-cm-long horizontal sections of spinal cords containing the lesion/graft site were sectioned on a cryostat set at 30 mm thickness. Coronal sections from the spinal cord, rostral and caudal to the T3 lesion/transplant site, were examined. Immunohistochemistry was performed to assess survival, maturation, integration, and outgrowth of grafted neurons as previously described (Lu et al., 2003) . Free-floating sections were incubated with primary antibodies against jellyfish GFP (rabbit, Invitrogen at 1:1,500 or goat from Chemicon at 1:1,500 to label GFP-expressing neural stem cells); GFAP (mouse from Chemicon at 1:1500 or rabbit from Dako at 1:1500 to label astrocytes); NeuN (mouse from Chemicon at 1:200 to label mature neurons); ChAT (goat from Chemicon at 1:200 to label spinal cord motor neurons and motor axons); MAP-2 (mouse from Chemicon at 1:10,000 to label mature neurons); ßIII tubulin (mouse from Chemicon at 1:500 to label immature and mature neurons); neurofilament (NF; mouse from Chemicon at 1:1,500 to label axons); serotonin (5-HT; polyclonal antibody from Immunostar at 1:20,000 to label raphespinal axons); myelin-associated glycoprotein (MAG; mouse from Chemicon at 1:200 to label myelin); glutamic acid decarboxylase 65 or 67 (GAD65, goat from RD System or GAD67, mouse from Millipore at 1:1,000 to label gabaergic neurons/terminals); vesicular glutamate transporters 1/2 (vGlut1/2, mouse from Chemicon at 1:1,000 to label glutamatergic terminals); synaptophysin (mouse from Chemicon at 1:1,000 to label presynaptic terminals); adenomatous polyposis coli (APC, monoclonal antibody from Oncogene at 1:400 to label oligodendrocytes); and phospho-S6 kinase (p-S6, rabbit from Cell Signaling Technology at 1:200 to label ribosomal protein S6 phosphorylated at serine 235 and 236). Sections were incubated overnight at 4 C and then incubated in Alexa 488, 594, or 647 conjugated goat or donkey secondary antibodies (1:250, Invitrogen) for 2.5 hr at room temperature. For nuclear staining, DAPI (200 ng/ml) was added to the final wash. BDA-labeled reticulospinal tract axons were detected by double fluorescent labeling with GFP. After blocking with 5% donkey serum, every sixth section was incubated with primary antibody directed against GFP (rabbit) and Alexa 594-conjugated streptavidin (to bind to BDA-labeled reticulospinal tract axons) overnight at 4 C. After washes, sections were incubated with Alexa 488 conjugated donkey anti-rabbit secondary antibodies for 2.5 hr at room temperature. For examination and quantification of GFP-labeled axons, light-level GFP immunolabeling was performed in every sixth section incubated overnight at 4 C with GFP primary antibody (rabbit at 1:3,000) and then with horseradish peroxidase (HRP) conjugated secondary antibodies (1:50, Vector Laboratory, Burlingame, CA) for 1 hr at room temperature. Diaminobenzidine (0.05%) with nickel chloride (0.04%) were used as chromagens, with reactions sustained for 10 min at room temperature.
Quantification of Neural Cell Density and Axon Number Cellular differentiation was determined by counting individual cells labeled for NeuN, GFAP, or APC within a fixed box size of 1,600 3 1,200 pixels at 4003 magnification within the graft, divided by the total number of cells per sample box labeled with DAPI. Two randomly selected fields corresponding to the graft epicenter were counted in each subject for each label, and all analyses were conducted in a blinded manner. An average of 170, 150, and 92 NeuN-, APC-, and GFAP-labeled cells were counted in each of six grafted animals, respectively, and divided by the mean number of DAPI-labeled nuclei in the sampled field (a mean of 586 DAPI-labeled nuclei/field). The number of GFP-labeled axons emerging from a typical graft placed at the T3 transection site was quantified by using StereoInvestigator (MicroBrightField, http://www. mbfbioscience.com) as previously described (Rosenzweig et al., 2010) . Briefly, in every sixth sagittal section, a dorsoventral line was drawn 500 mm caudal to the graft/host interface under 403 magnification. The tissue was then examined under 6003 magnification, and GFP-labeled axons that intersected this line were marked and counted. The sampling fraction was 8.3%. In addition, GFP axon number was quantified in every sixth section both rostral and caudal to the graft to study molecular mechanisms of axonal growth after rapamycin treatment. Lesion margins were determined by using GFAP and GFP double fluorescent immunolabeling, and axons crossing a vertical line in horizontal sections 1, 3, and 5 mm rostral and caudal to the lesion/graft border were counted at 2003 magnification. Total axon number/subject was estimated by multiplying by the sampling fraction. Observers were blinded to group identity in all surgical and quantitative procedures.
Semiquantitative RT-PCR For RT-PCR of NgR1, 500 ng total RNA from E14, P1, or adult spinal cord was used as the template in a 20 ml reaction with random hexamer priming using the Superscript III kit (Invitrogen). 1 ml RT product was used in standard PCR with different cycle numbers. PCR primers: 1)ﾊGAPDH:ﾊTGGAGTCTACTGG CGTCTT,ﾊTGTCATATTTCTCGTGGTTCA and 2) NgR1: AAGAGGGCGTC CTCCGG, CGGCATGACTGGAAGCT.
Electron Microscopy
Electron microscopic analysis of synapse formation and myelination was performed according to the methods of Knott et al. (2009) . Briefly, two rats with T3 complete transections that received rat neural stem cell grafts were perfused with 4% paraformaldehyde plus 0.25% glutaraldehyde (survival time 3 months), and spinal cord parenchyma 2 mm caudal to the lesion/graft site was sectioned in the coronal plane and then immunolabeled for GFP with Diaminobenzidine (DAB) and nickel chloride. Sections were then postfixed with 1% osmium tetroxide, dehydrated, embedded in Durcupan resin, and sectioned at 60 nm thickness. Individual GFP-labeled axons or axonal terminals were located and assessed by using an FEI 200KV Sphera microscope at the UCSD CryoElectron Microscopy Facility.
Electrophysiology
Descending transmission of electrical activity through grafts was assessed by using previously described techniques (Bradbury et al., 2002) . In brief, a bipolar stimulating electrode, consisting of a pair of 85 mm tungsten microelectrodes (0.5 MOhm, WPI, Inc.) spaced 1 mm apart, was lowered 300-500 mm into the cord at the C7 spinal segment. Brief (0.1 ms) square wave pulses were delivered at 3-5 s intervals, and responses were averaged over 40 trials. Field responses were recorded by using a 1 mm diameter silver ball electrode placed (i) at T6, three segments caudal to the graft (see Figure 6B ). Confirmation of electrical transmission through the graft was confirmed by retransecting the cord immediately above the graft and by applying kynurenic acid (50 mM in ACSF) to the graft at the T3 segment.
Functional Analysis
The BBB open field 21 point locomotion rating scale (Basso et al., 1996) was assessed weekly by two independent observers blinded to group identity.
Statistical Analysis
In all quantification procedures and behavioral analyses, observers were blinded to the nature of the experimental manipulation. Multiple group comparisons were made using one-way analysis of variance (ANOVA; JMP software) at a designated significance level of 95%. Two-group comparisons were tested by Student's t test. Data are presented as mean ±SEM.
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